OpenVSafe by OpenVAERS
Search V-safe

YUZ-29809-77215

2 vaccinations 8 coded responses 22 check-ins 8 free-text entries 2 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
441 / OH
Registered
2021-03-25
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-25
    Registered in v-safe
  2. 2021-03-25
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-25
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site
    Adult check-in
  4. 2021-03-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  6. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-04-08
    Survey response — day 14, dose 1
    MedDRA: Asthma, Dyspnoea, Oropharyngeal pain, Pre-existing disease, Throat irritation — Feeling: Good · Be unable to do your normal daily activities
    Free text: Awaken with sore scratchy throat. Short of breath Probably due to asthma. Took a albuterol/ ipratopium breathing treatment, which alleviated the issue.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-15
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-15
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  14. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Wheezing — Feeling: Good · Be unable to do your normal daily activities
    Free text: Cough and wheezing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-22
    Survey response — day 7, dose 2
    MedDRA: Dyspnoea, Wheezing — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Wheezing and short of breath
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-29
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-05-06
    Survey response — day 21, dose 2
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Asthma not under control after last dose of prednisone
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-15
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  22. 2021-05-20
    Survey response — day 35, dose 2
    MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Asthma flaring up
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-07-15
    Survey response — 3 months, dose 2
    MedDRA: Asthma, Pre-existing disease, Respiratory tract infection viral — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Asthma flare up with some kind of viral respiratory issue
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-10-14
    Survey response — 6 months, dose 2
    MedDRA: Vocal cord dysfunction — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Vocal cord dysfunction
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-14
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  26. 2021-10-18
  27. 2022-04-18
    Survey response — 12 months, dose 2
    MedDRA: Asthma, Cough, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Asthma flare up recently and currently still experiencing lingering cough
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-04-18
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2022-04-19

Vaccinations

DoseDateManufacturerCo-administered
12021-03-25Pfizer-BioNTech
22021-04-15Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-10-14 Unsuccessful
2022-04-18 Unsuccessful

Free text

Release 7 — day 14, dose 1

2021-04-08

Symptoms: Awaken with sore scratchy throat. Short of breath Probably due to asthma. Took a albuterol/ ipratopium breathing treatment, which alleviated the issue.

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): Cough and wheezing

Release 7 — day 7, dose 2

2021-04-22

Systemic reaction (other): Wheezing and short of breath

Release 8 — day 21, dose 2

2021-05-06

Symptoms: Asthma not under control after last dose of prednisone

Release 8 — day 35, dose 2

2021-05-20

Symptoms: Asthma flaring up

Release 9 — 3 months, dose 2

2021-07-15

Symptoms: Asthma flare up with some kind of viral respiratory issue

Release 10 — 6 months, dose 2

2021-10-14

Symptoms: Vocal cord dysfunction

Release 11 — 12 months, dose 2

2022-04-18

Symptoms: Asthma flare up recently and currently still experiencing lingering cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthma ✓ ✓ ✓
SDCough · · ✓
SDDyspnoea ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiratory tract infection viral ✓ · ✓
SDThroat irritation ✓ ✓ ✓
SDVocal cord dysfunction · · ✓
SROCough ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROWheezing ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release